TrialClinical drug investigation2018

Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence.

Sara Nazha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.